| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 3 | +100.00% | -34.82% | -1.01% | -33.81% | -34.58% | — |
| 14d | 3 | +100.00% | -38.69% | -2.77% | -35.91% | -36.70% | — |
| 30d | 3 | +100.00% | -37.33% | -4.05% | -33.27% | -33.85% | — |
| 60d | 3 | +100.00% | -39.56% | +5.17% | -44.73% | -44.69% | — |
| 90d | 3 | +100.00% | -45.11% | — | — | — | — |
| 180d | 3(3 pending) | — | — | — | — | — | — |
| 1y | 3(3 pending) | — | — | — | — | — | — |
| 2y | 3(3 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| OLMA OLEMA PHARMACEUTICALS, INC. | SALE CHIEF LEGAL OFFICER | 233 | $24.69 | $5.8K | 0 | Mar 4, 2026 | Mar 5, 2026 ↗ | View → |
| OLMA OLEMA PHARMACEUTICALS, INC. | SALE CHIEF LEGAL OFFICER | 25,000 | — | — | 410,000 | Mar 4, 2026 | Mar 5, 2026 ↗ | View → |
| OLMA OLEMA PHARMACEUTICALS, INC. | SALE CHIEF LEGAL OFFICER | 24,767 | $24.25 | $600.6K | 233 | Mar 4, 2026 | Mar 5, 2026 ↗ | View → |
| OLMA OLEMA PHARMACEUTICALS, INC. | PURCHASE CHIEF LEGAL OFFICER | 25,000 | $4.37 | $109.3K | 25,000 | Mar 4, 2026 | Mar 5, 2026 ↗ | View → |
| OLMA OLEMA PHARMACEUTICALS, INC. | PURCHASE CHIEF LEGAL OFFICER | 15,000 | $4.37 | $65.5K | 15,000 | Mar 3, 2026 | Mar 5, 2026 ↗ | View → |
| OLMA OLEMA PHARMACEUTICALS, INC. | SALE CHIEF LEGAL OFFICER | 15,000 | — | — | 435,000 | Mar 3, 2026 | Mar 5, 2026 ↗ | View → |
| OLMA OLEMA PHARMACEUTICALS, INC. | SALE CHIEF LEGAL OFFICER | 15,000 | $23.01 | $345.1K | 0 | Mar 3, 2026 | Mar 5, 2026 ↗ | View → |
| OLMA OLEMA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 220,000 | — | — | 220,000 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| OLMA OLEMA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 56,250 | — | — | 56,250 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| OLMA OLEMA PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 450,000 | — | — | 450,000 | Feb 28, 2025 | Mar 3, 2025 ↗ | View → |
| APVO APTEVO THERAPEUTICS INC. | PURCHASEGRANT Stock grant | 134,800 | — | — | 134,800 | Feb 18, 2020 | Mar 19, 2020 ↗ | View → |